Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Pharmacology & Therapeutics|February 11, 2017
DNA vaccines for prostate cancerChristopher D Zahm, Viswa Teja Colluru, Douglas G McNeelCancer Immunology Research|June 22, 2017
Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8<sup>+</sup> T CellsChristopher D Zahm, Viswa T Colluru, Douglas G McNeelOncoimmunology|November 18, 2016
Mini-intronic plasmid vaccination elicits tolerant LAG3<sup>+</sup> CD8<sup>+</sup> T cells and inferior antitumor responsesViswa Teja Colluru, Christopher D Zahm, Douglas G McNeelOncoimmunology|May 17, 2021
PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacyChristopher D Zahm, Jena E Moseman, Lauren E Delmastro, et al.Cancer Immunology Research|September 12, 2018
TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8Christopher D Zahm, Viswa T Colluru, Sean J McIlwain, et al.American Journal of Cancer Research|February 14, 2019
Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse modelsEmily B Ehlerding, Hye Jin Lee, Dawei Jiang, et al.Cancers|October 3, 2020
Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)Melissa Gamat-Huber, Donghwan Jeon, Laura E Johnson, et al.Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Clonal structure of carcinogen-induced intestinal tumors in miceAndrew T Thliveris, Linda Clipson, Alanna White, et al.Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Transformation of epithelial cells through recruitment leads to polyclonal intestinal tumorsAndrew T Thliveris, Brittany Schwefel, Linda Clipson, et al.Biorxiv : the Preprint Server for Biology|February 9, 2026
Engineering "physically optimized" T cells for increased sampling of complex tumor microenvironmentsHongrong Zhang, Zhongming Chen, Guhan Qian, et al.Pageof 2